dsip-research DSIP – Research Peptide DSIP (RUO) Sleep and Neuroendocrine

Some individuals who have taken Tesofensine in clinical trials have reported experiencing significant appetite suppression, leading to noticeable weight loss without constantly feeling hungry

Bimagrumab has the potential of improving the WL quality by preserving lean mass and could become an attractive treatment option for sarcopenic obesity

Every vial is handled with care to protect peptide stability throughout the fulfillment process

Clinical trial results suggest that tirzepatide will provide a major advancement in the treatment of T2D and its associated metabolic derangements such as cardio-renal-metabolic disease

For further details, please see our previous blog on the LDT Final Rule